COMMUNIQUÉS West-GlobeNewswire

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to September 3, 2024

05/08/2024 - 22:35

New York, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”) a special purpose acquisition company, announced today that on August 2, 2024, its sponsor, [...]

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

05/08/2024 - 22:30

(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 05 août 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]

Monthly information on share capital and company voting rights

05/08/2024 - 22:30

(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]

ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs

05/08/2024 - 22:15

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]

Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update

05/08/2024 - 22:15

Top-line data expected in December 2024 after having completed enrollment for Phase 2b trial to treat atopic dermatitis (AD) with ANB032, our BTLA agonist Top-line data accelerated and now anticipated in Q1 2025 for [...]

OrthoPediatrics Corp. Reports Second Quarter 2024 Financial Results and Reaffirms Full Year 2024 Revenue Guidance

05/08/2024 - 22:12

Record Second Quarter 2024 Revenue Increased 33% Year-over-Year WARSAW, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on [...]

OrthoPediatrics Corp. Announces Private Financing

05/08/2024 - 22:10

Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital WARSAW, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused [...]

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

05/08/2024 - 22:09

Increases 2024 revenue guidance to $165 million - $167 million Expects to achieve positive Adjusted EBITDA in Fourth Quarter 2024 SANTA CLARA, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a [...]

PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer

05/08/2024 - 22:05

Krulik Brings More than 20 Years of Leadership Experience in Finance and Accounting DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. , dba PetMeds and parent company of PetCareRx , (Nasdaq: [...]

RxSight, Inc. Reports Second Quarter 2024 Financial Results

05/08/2024 - 22:05

ALISO VIEJO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

89bio Reports Second Quarter 2024 Financial Results and Corporate Updates

05/08/2024 - 22:05

–The Phase 3 ENLIGHTEN-Fibrosis trial in patients with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and the Phase 3 ENLIGHTEN-Cirrhosis trial in patients with compensated cirrhosis (F4) are [...]

Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance

05/08/2024 - 22:05

Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP loss of $28.9 [...]

Y-mAbs Announces Second Quarter 2024 Conference Call and Webcast

05/08/2024 - 22:05

NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]

Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia

05/08/2024 - 22:05

This joint effort will harness PacBio's state-of-the-art HiFi sequencing technology to offer profound insights into genetic diversity, disease mechanisms, and clinical diagnoses within Singapore’s multi-ethnic [...]

Oncocyte Announces August Investor Conferences Participation

05/08/2024 - 22:05

IRVINE, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a molecular diagnostics technology company, today announced that CEO Josh Riggs and CFO Andrea James plan to participate in the following [...]

Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024

05/08/2024 - 22:05

RADNOR, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD [...]

Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates

05/08/2024 - 22:05

Top-line data from Phase 1 trial of TERN-601 (oral GLP-1) for obesity expected in September 2024 Interim data from initial dose escalation cohorts of Phase 1 CARDINAL trial evaluating TERN-701 (allosteric BCR-ABL) in [...]

Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024

05/08/2024 - 22:05

MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

Anika to Participate in the Sidoti Virtual Investor Conference

05/08/2024 - 22:01

BEDFORD, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the [...]